In many cases, the dose-response relation is exponential, that is, the fraction F of a population surviving a dose D of agent is given by In this case a plot of log F against D is a straight line with a slope of -x intercepting the zero ordinate (D 0) where F = 1. This relationship is most readily accounted for by supposing the existence in the cell of a single vital target inactivated by random contact with discrete quanta of the agent. The existence of a repair mechanism or the necessity to inactivate multiple targets in each cell gives the curve a shoulder near its origin. An approximation to this latter type of curve is given by F e1-(1 e-D)f.
Exponential curves are typical of radiation, administered in vivo or in vitro (Puck and Marcus, 1956; Robinson et al., 1967; Elkind and Whitmore, 1967) but are also given by cells exposed in vitro to various alkylating agents (Levis, 1963; Berry, 1964) or 5-fluorouracil (Madoc-Jones and .
Many attempts have been made to fit to an exponential relation dose-response curves obtained in vivo for agents other than radiation. The fit is undoubtedly good with cyclophosphamide and 1,3-bis (2-chloroethyl)-1-nitrosourea (Skipper, Schabel arid Wilcox, 1964 Wilcox, , 1965 . However, the curves obtained for the destruction of murine leukaemic cells by such agents as 6-mercaptopurine and methotrexate cannot be regarded as exponential (Fig. 1A) . In Fig. LB 
In other words, dose-response curves of L 1210 cells in mice treated with methotrexate, 5-fluorouracil or 6-mercaptopurine are not exponential but hyperbolic in form, the product of the surviving fraction and the dose (or a power of the dose) being a constant. When y = 1, cell survival is simply inversely proportional to dose, and the product of the surviving fraction and the dose is equal to the threshold dose Do.
The fact that results of experiments with cell-sterilizing agents are not often plotted in this way in the literature, and the persisting myth that antitumour agents are generally radiomimetic perhaps account for this quite common relationship having been overlooked. A good example of a hyperbolic dose-response curve with a slope of -1 was given by Berry (1964) for the action of mannomustine on cells in vitro. Berry pointed out that this curve was evidence that mannomustine was not " radiomimetic " as radiation gave an exponential curve. It has to be emphasized that, if the experimental results are determined over too restricted a dose-range, it may not be possible to say whether a dose-response curve is exponential or hyperbolic. This is the case, for instance, with the data for 5-fluorouracil given by Skipper et al. (1965) covering a 5-fold dose range ( Fig. 1) and those of Bruce, Meeker and Valeriote (1966) (1967) for the same drug, covering 4-to 10-fold dose-ranges. In both cases the points would fit exponential and hyperbolic curves equally well. As many antineoplastic agents are also immunosuppressive, dose-response relations for this effect were accordingly investigated.
MATERIALS AND METHODS

Animal8
Colony-bred male A2G mice, weighing [16] [17] [18] [19] [20] [21] [22] [23] [24] (Berenbaum, 1967) . Although the peak number of plaque-forming cells is found 4 days after immunization, sampling was carried out on the 5th day because it is at this time that the maximum differences between control and treated animals appear (Berenbaum, 1966) .
RESULTS
Results of representative experiments are shown in Fig. 2 , in which the number of plaques per spleen (expressed as a fraction of the control number) is plotted on a logarithmic scale against dose. The scale for dose is linear in the case of the alkylating agents aniline mustard, cyclophosphamide and melphalan, and logarithmic in the case ofthe antimetabolites methotrexate, 6-thioguanine and 5-fluorouracil. It is evident that these scales allow straight lines to be drawn through the experimental points over most of the dose range, although there is a tendency for the dose-response curves for methotrexate and 6-thioguanine to flatten out in the lethal dose range. The dose-response curves for the alkylating agents used here are therefore exponential, whereas those for the antimetabolites have a hyperbolic form.
DISCUSSION
The results presented here, and those of Skipper, Schabel and Wilcox (1964, 1965) suggest that there is a fundamental difference between the dose-response curves given by radiation and alkylating agents, which are exponential, and those given by antimetabolites, which are hyperbolic. The reason for this difference can only be a matter for speculation at present, but one explanation is that the interaction between a molecule of alkylating agent or an ionizing event on the one hand and a cell component on the other does not affect the probability of other, similar interactions, either simultaneous or subsequent, whereas the interaction between a molecule of antimetabolite or metabolite and an enzyme site strongly affects the probability of another such reaction. The dose-response relation for alkylating agents and ionizing radiation is therefore governed by classic target (Webb, 1963) , where Vi is the rate of the inhibited reaction, Vm the maximal rate at enzymesaturating substrate concentration, (S) and (I) the concentrations of substrate and inhibitor, and K. and Ki the dissociation constants for the enzyme-substrate and enzyme-inhibitor complexes. The variation of reaction rate with inhibitor concentration is shown in Fig. 3 , curve A, both parameters being plotted on logarithmic scales. It can be seen that, the higher the concentration of inhibitor, the more closely the relation between reaction rate and inhibitor concentration approximates to a hyperbolic one. At low concentrations, the rate approaches that of the uninhibited reaction asymptotically. Now, the fraction of a cell population that survives and reproduces is equal to the average probability that its component cells retain reproductive integrity. It may reasonably be suggested that this probability for any individual cell is directly related to the rates at which critical enzyme-mediated reactions can be carried out during the proliferative cycle. It would then follow, as shown in Fig. 3 , that, at high concentrations of antimetabolite, the surviving fraction of a cell population would be inversely related to the concentration. Other factors being equal, the in vivo concentration of a drug is proportional to the dose. Therefore, at high doses the surviving fraction of a cell population will be inversely proportional to the dose of antimetabolite while, at low doses, cell survival will approach the F = 1 abscissa asymptotically. The experimentally determined survival curves, however, cut the F 1 abscissa at a threshold dose. Two possible explanations for this may be considered. Firstly, some enzymes concerned in cell proliferation may be present in excess, so that proliferation is not impaired until a certain proportion of enzyme has been blocked. In other words, the surviving fraction of a proliferating population may not fall below 1 until the rate of the reaction mediated by the enzyme falls to 0.5, or some other fraction, of that in untreated cells. In effect, this would result in a shift in the abscissae for cell survival (Fig. 3B ) and the curve would cut the F = 1 abscissa at a threshold dose.
Secondly, the existence of a threshold dose could be explained by dose-dependent repair mechansims. If fractional cell survival F in the absence of repair is proportional to residual enzyme activity (Vi/ Vm in equation 4), allowance for repair that decreases in effectiveness with increasing dose may be made by appropriate modification of equation (4) Fig. 3 , curve C. These closely approach curve A at high doses, but increasingly diverge from it at lower doses to cut the F 1 abscissa.
It is not clear why some antimetabolites give hyperbolic dose-response curves with slopes steeper than -1 (Fig. 1, 6-mercaptopurine; Fig. 2 , 5-fluorouracil). It is possible that such curves are produced when lesions caused by the agent interact. Alternatively they may be accounted for by repair mechanisms that are more effective at low doses (with b > 1 in equation 5). In this case the doseresponse curve would have an initially steeper portion, and approach a slope of -1 at doses at which repair became relatively ineffective.
It is also interesting to note that the character of the dose-response curve given by one and the same agent may depend on whether it is determined in vitro or in vivo. For instance, 5-fluorouracil, which gives hyperbolic curves in vivo (Fig. 2) gives exponential curves when tested on L-cells in vitro (Madoc-Jones and Bruce, 1967) . Again, mannomustine gives a hyperbolic dose-response curve in vitro (Berry, 1964) although it is an alkylating agent and would be expected to give an exponential curve in vivo. WVhatever the reasons for these discrepancies, they reinforce the idea that evidence as to the modes of action of these agents obtained in in vitro experiments can be extrapolated to in vivo conditions only with considerable reservation.
SUMMARY
Many commonly used antitumour and immunosuppressive agents act by impairing the reproductive integrity of proliferating cells. The common assumption that the relation between dose and cell survival for such agents is generally exponential is incorrect. The dose-response curve for antimetabolites is shown to be characteristically hyperbolic, i.e. the product of the surviving fraction of a proliferating cell population and the dose of agent (or a power of the dose) is a constant. The hyperbolic form of these curves is probably due to the competitive nature of antimetabolite action. Alkylating agents resemble radiation in showing exponential dose-response curves. Such curves may be expected when discrete quanta of agent react independently and at random with critical cell targets. 
